Previous Article | Next Article ![]()
Clinical Microbiology Reviews, January 2000, p. 122-143, Vol. 13, No. 1
Center for Medical Mycology, Mycology Reference
Laboratory, University Hospitals of Cleveland, and Department of
Dermatology, Case Western Reserve University, Cleveland, Ohio
44106-5028
0893-8512/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Potential Role of Phospholipases in Virulence and
Fungal Pathogenesis
SUMMARY
INTRODUCTION
DEFINITION OF PHOSPHOLIPASES AND RATIONALE IN CONSIDERING
THEM FOR A ROLE IN VIRULENCE
PHOSPHOLIPASES IN ORGANISMS OTHER THAN FUNGI
Bacterial Phospholipases
Clostridium perfringens.
Listeria monocytogenes.
Pseudomonas aeruginosa.
Bacillus cereus.
Rickettsia.
Corynebacterium pseudotuberculosis.
Protozoan Phospholipases
PHOSPHOLIPASES IN PATHOGENIC FUNGI
Phospholipases of Candida albicans
Early work on candidal phospholipases.
(i) Candidal
phospholipase.
(ii) Production of phospholipase by various candidal
species.
(iii) Types of candidal phospholipases.
Evidence correlating phospholipases and virulence.
Cloning of the gene(s) encoding candidal phospholipases.
(i) Candidal phospholipases B.
(ii) Candidal phospholipase D.
Disruption of phospholipase B1.
Phenotypic characterization of phospholipase
B1-deficient mutants.
Testing of phospholipase B1-deficient mutants
in murine models of candidiasis.
(i) Hematogenous-dissemination model.
(ii) Oral-intragastric infant-mouse model.
Expression of phospholipase B1 during host
tissue invasion.
Phospholipases of Candida glabrata
Phospholipases of Cryptococcus neoformans
Correlation of phospholipase and virulence.
Cloning of the gene encoding phospholipase B.
Phospholipases of Aspergillus Species and
Their Relation to Virulence
MECHANISMS BY WHICH PHOSPHOLIPASE AUGMENTS CANDIDAL
VIRULENCE
Influence of Phospholipase B1 on Candidal
Adherence to Host Cells
Involvement of Phospholipase B1 in
Host Cell Injury and Penetration
Do Fungal Extracellular Phospholipases Have Other Functions
That Facilitate Virulence in Addition to Cell Lysis and Damage?
Role of Fungal Phospholipases in the Antifungal
Activity of Amphotericin B Lipid Complex
FUNGAL PHOSPHOLIPASES AS A THERAPEUTIC AND DIAGNOSTIC
TARGET
CONCLUSION AND OUTLOOK
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
Microbial pathogens use a number of genetic strategies to invade the host and cause infection. These common themes are found throughout microbial systems. Secretion of enzymes, such as phospholipase, has been proposed as one of these themes that are used by bacteria, parasites, and pathogenic fungi. The role of extracellular phospholipase as a potential virulence factor in pathogenic fungi, including Candida albicans, Cryptococcus neoformans, and Aspergillus, has gained credence recently. In this review, data implicating phospholipase as a virulence factor in C. albicans, Candida glabrata, C. neoformans, and A. fumigatus are presented. A detailed description of the molecular and biochemical approaches used to more definitively delineate the role of phospholipase in the virulence of C. albicans is also covered. These approaches resulted in cloning of three genes encoding candidal phospholipases (caPLP1, caPLB2, and PLD). By using targeted gene disruption, C. albicans null mutants that failed to secrete phospholipase B, encoded by caPLB1, were constructed. When these isogenic strain pairs were tested in two clinically relevant murine models of candidiasis, deletion of caPLB1 was shown to lead to attenuation of candidal virulence. Importantly, immunogold electron microscopy studies showed that C. albicans secretes this enzyme during the infectious process. These data indicate that phospholipase B is essential for candidal virulence. Although the mechanism(s) through which phospholipase modulates fungal virulence is still under investigations, early data suggest that direct host cell damage and lysis are the main mechanisms contributing to fungal virulence. Since the importance of phospholipases in fungal virulence is already known, the next challenge will be to utilize these lytic enzymes as therapeutic and diagnostic targets.
INTRODUCTION
|
|
|---|
To aid in the invasion of host tissues, microbial cells possess constitutive and inducible hydrolytic enzymes that destroy or derange constituents of host cell membranes, leading to membrane dysfunction and/or physical disruption (167). Since membranes are made up of lipids and proteins, these biochemicals constitute the target of enzyme attack. Pathogenic fungi (e.g., Candida albicans) secrete enzymes which are considered to be integral to their pathogenesis; these are categorized into two main types, proteinases (72, 73), which hydrolyze peptide bonds, and phospholipases (75), which hydrolyze phospholipids. In this review, we focus on fungal phospholipases. It should be emphasized that this field is evolving rapidly and that most of the data reviewed in this article were published recently. New insights into the biology and contribution of these enzymes to fungal virulence will be forthcoming in the near future.
DEFINITION OF PHOSPHOLIPASES AND RATIONALE IN CONSIDERING
THEM FOR A ROLE IN VIRULENCE
|
|
|---|
The term "phospholipases" refers to a heterogeneous group of enzymes that share the ability to hydrolyze one or more ester linkage in glycerophospholipids. Although all phospholipases target phospholipids as substrates, each enzyme has the ability to cleave a specific ester bond (Fig. 1a). Thus, qualifying letters, such as A, B, C, and D, are used to differentiate among phospholipases and to indicate the specific bond targeted in the phospholipid molecule (4). For example, phospholipase A1 (PLA1) hydrolyzes the fatty acyl ester bond at the sn-1 position of the glycerol moiety, while phospholipase A2 (PLA2) removes the fatty acid at the sn-2 position of this molecule. The action of PLA1 (EC 3.1.1.32) and PLA2 (EC 3.1.1.4) results in the accumulation of free fatty acids and 2-acyl lysophospholipid or 1-acyl lysophospholipid, respectively. The fatty acid still linked to the lysophospholipid is, in turn, cleaved by other enzymes termed lysophospholipases (Lyso-PL) (EC 3.1.1.5) (Fig. 1b). Phospholipase C (PLC) (EC 3.1.4.3) hydrolyzes the phosphodiester bond in the phospholipid backbone to yield 1,2-diacylglycerol and, depending on the specific phospholipid species involved, phosphatidylcholine, phosphatidylethanolamine, etc. The second phosphodiester bond is cleaved by phospholipase D (PLD) (EC 3.1.4.4) to yield phosphatidic acid and choline or ethanolamine, again depending on the phospholipid class involved (4).
|
Although phospholipase B (PLB) (synonyms: lysophospholipase, lysophospholipase-transacylase) refers to an enzyme that can remove both sn-1 and sn-2 fatty acids, its nomenclature is confusing (4). This confusion arises because PLB has both hydrolase (fatty acid release) and lysophospholipase-transacylase (LPTA) activities. The hydrolase activity allows the enzyme to cleave fatty acids from both phospholipids (PLB activity) and lysophospholipids (lysophospholipase [Lyso-PL] activity), while the transacylase activity allows the enzyme to produce phospholipid by transferring a free fatty acid to a lysophospholipid (Fig. 1b). The finding that PLB has both hydrolase and acyltransferase activities has been reported for enzymes purified from C. albicans, Penicillium notatum, and Saccharomyces cerevisiae (100, 122, 164, 224, 225). This complex pattern of activity led to difficulties in the nomenclature of the enzyme, with some authors naming it PLB (as in the case of S. cerevisiae and P. notatum) and others naming it LPTA (10, 122, 193). Recent cloning and disruption of genes encoding PLB provided further evidence that this enzyme has both PLB and Lyso-PL activities. Deletion of caPLB1, the gene encoding PLB from C. albicans, showed that both PLB and Lyso-PL activities were reduced in the PLB1-deficient mutant relative to the wild type, confirming that caPLB1 encodes an enzyme responsible for the PLB and Lyso-PL activities (75, 101). Similar findings were reported for PLB deletion in S. cerevisiae (100).
Invasion of host cells by microbes entails penetration and damage of the outer cell envelope. This transmigration process is mediated, most probably, by either physical or enzymatic means or a combination of the two. Phospholipids and proteins represent the major chemical constituents of the host cell envelope. Therefore, enzymes capable of hydrolyzing these chemical classes, such as phospholipases and proteinases, are likely to be involved in the membrane disruption processes that occur during host cell invasion. By cleaving phospholipids, phospholipases destabilize the membrane and cell lysis results (166). Evidence implicating phospholipases in host cell penetration, injury, and lysis by microorganisms has been reported for Rickettsia rickettsii (207), Toxoplasma gondii (160, 161), Entamoeba histolytica (154), and C. albicans (101). Consequently, phospholipases have been included among the virulence factors that damage host cells (166).
PHOSPHOLIPASES IN ORGANISMS OTHER THAN FUNGI
|
|
|---|
Besides fungi, which are the subject of this review, extracellular
phospholipases have been implicated as pathogenicity factors for
bacteria (Table 1). Since bacterial
phospholipases have been the subject of at least two recent reviews
(183, 194), to avoid repetition, only a brief description of
these enzymes and their role in virulence is covered in this article.
Furthermore, including some information about phospholipases from
organisms other than fungi will show a global perspective of microbial
phospholipases.
|
Bacterial Phospholipases
Clostridium perfringens. PLC (synonyms: alpha-toxin, lecithinase), which is one of the most active bacterial phospholipases, is 1 of at least 12 different soluble antigens referred to as toxins, produced by Clostridium perfringens, that may be involved in pathogenesis. The findings that clostridial PLC was a potent toxin (109, 110, 123) with hemolytic (162, 195), lethal (196), dermonecrotic (115), vascular permeabilization (186), and platelet-aggregating (134, 185) properties attracted a large number of investigators to study this secreted protein, making it the most extensively studied bacterial toxin. Thus, it is not surprising that extensive reviews have been written about this enzyme (67, 79, 194), its application to the study of cell membranes (3, 5, 48, 126, 159, 229), and its role in virulence (183).
Over the past 60 years, extensive data have accumulated concerning both the physiology of toxin production by C. perfringens (179) and some of the physical and biological properties of the enzyme (115). However, many of the earlier data have been difficult to interpret because of the lack of purity of the toxin preparations used (127). In these earlier studies, many authors used preparations of the enzyme from commercial or other sources with insufficient or no regard for the fact that these preparations, unless produced under rigorous purification standards, may contain as many as 11 contaminating substances (115). Furthermore, purification of this enzyme is difficult. Fortunately, recent molecular biology techniques allowed the cloning and sequencing of the gene encoding clostridial PLC (195, 227) and subsequent synthesis of purified recombinant enzyme (227). Availability of the gene and the purified protein made studies aimed at defining the role of PLC in the virulence of C. perfringens feasible. To study the pathogenesis of C. perfringens-mediated gas gangrene, Awad et al. (6) used reverse genetics to construct a suicide plasmid in which the plc gene, encoding PLC, was inactive. Using this plasmid, they isolated mutants that had lost their ability to produce detectable PLC. Comparing the mutants and their parent in a mouse virulence model showed that the mutants were markedly less pathogenic than the parent strain (6). Unlike animals infected with the phospholipase-deficient mutants, which showed minimal swelling, muscle destruction, inflammation, or necrosis of the infected tissues and remained active with an otherwise healthy appearance, animals challenged with the parent strain had extensive swelling of the infected foot, leg, and hip, as well as a severely necrotic infected foot, demonstrable signs of hematuria, and extensive muscle destruction. This study provided definitive genetic evidence of the essential role of PLC in gas gangrene or clostridial myonecrosis. For a more in-depth review of clostridial PLC with regard to its substrate specificity, molecular architecture, interaction with phospholipids and membranes, and role in disease, the reader is referred to excellent reviews by Titball (194) and Songer (183).Listeria monocytogenes. Similar to C. perfringens, L. monocytogenes secretes a number of extracellular enzymes including listeriolysin (encoded by hly) and two phospholipases: i) PI-PLC or PLC-A, encoded by plcA, which is an inositol-specific PLC (21), and (ii) PC-PLC or PLC-B, encoded by plcB, which is a broadly active PLC with the ability to hydrolyze most cellular phospholipids (203). Although each phospholipase may contribute to the virulence of L. monocytogenes by itself (21, 119, 203), elegant work by Portnoy and colleagues showed that the two phospholipases play overlapping roles in the pathogenesis of L. monocytogenes (178). In their study, mutants harboring a deletion in each PLC, as well as a double mutant lacking both enzymes, were characterized with regard to virulence. Abolishing PI-PLC and PC-PLC resulted in strains that were 2- and 20-fold less virulent than the parent strain, respectively. In addition, these strains were defective in escape from the vacuole and in cell-to-cell spread, depending on which enzyme was deleted. Interestingly, the mutant lacking both PLCs was 500-fold less virulent in mice and was severely diminished in its ability to escape from the vacuole and to spread from cell to cell (178). These findings are consistent with the two enzymes having overlapping functions throughout the course of infection. Importantly, deleting a single gene resulted in only a modest reduction in virulence, while simultaneous deletion of the two genes in the same strain led to a highly significant decrease in the virulence, suggesting that the two enzymes have a synergistic effect on the ability of the organism to invade host tissues. For more details on entry of L. monocytogenes into phagocytic cells and the role of secreted enzymes, including phospholipases, in the ability of the organism to escape from the vacuole and transmigrate cell-to-cell, the reader is referred to references 144, 183, and 194.
Pseudomonas aeruginosa. Two distinct PLCs are produced by Pseudomonas aeruginosa: PLC-N (nonhemolytic) and PLC-H (hemolytic) (183). The genes (plcN and plcS) encoding these enzymes have been cloned (137). Although the expression and secretion of both enzymes are phosphate regulated, each enzyme has a distinct substrate specificity, with PLC-H hydrolyzing sphingomyelin in addition to phosphatidylcholine (PC), while PLC-N is active in phosphatidylserine and PC degradation (137). This difference in substrate specificity has a bearing on the efficiency with which these enzymes degrade eukaryotic membranes. Ostroff et al. (138) proposed that the two enzymes could work sequentially and synergistically to lyse host cells. PLC-H initiates membrane lysis by hydrolyzing PC and sphingomyelin (the major constituents of the membrane outer leaflet), and this is followed by the action of PLC-N which cleaves phosphatidylserine (the major constituent of the membrane inner leaflet). Furthermore, substrate specificity studies have shown that PLC-H preferentially cleaves phospholipids containing quaternary ammonium groups, such as phosphatidylcholine, which are found primarily in eukaryotic membranes and lung surfactants, but that it has minimal activity toward phospholipids such as phosphatidylethanolamine, which are found in the prokaryotic membrane (14). This selective ability may explain why the invading organism can lyse the host cells without damaging its own membrane.
Correlation between PLC-H and P. aeruginosa pathogenicity can be derived from studies showing that the enzyme is secreted in vivo and in experiments comparing the wild type with mutants in which this gene is deleted in animal models. Three lines of evidence suggest that PLC-H is secreted in vivo: (i) clinical isolates from the lungs produce PLC (13), (ii) PLC is produced when the bacterium is grown in bronchial washings (105), and (iii) high titers of antibody against PLC-H are detected in patients with chronic P. aeruginosa infection (62). Mutants disrupted in the plcS gene were generated and used to determine the role of PLC-H in pseudomonal virulence (138). In this study, the virulence of wild-type strains and plcS-disrupted mutants was compared in a mouse burn model of infection. A reduction was observed in the ability of the disruptant grown under phosphate-limiting conditions to kill mice (200-fold increase in the 50% lethal dose compared with the wild-type strain). Since virulence in these studies was phosphate dependent, mutants disrupted in plcR (a phosphate-regulatory gene) were generated to investigate its effect alone and combined with plcS. These studies showed that when the strains were grown under phosphate-limiting conditions, the virulence of the
plcS
plcR strain was 200- to 10,000-fold lower than that of the
parent strain (138). Interestingly, mutants with only plcR deleted were also attenuated in virulence even though
they produced greater amounts of PLC and hemolysin (138). In
spite of this apparent enigma, which suggests a role for
plcR in pseudomonal pathogenicity, the significantly greater
reduction in the pathogenicity of the double disruptant suggests that
PLC-H is associated with virulence (194).
Bacillus cereus. Several PLCs, including phosphatidylinositol-specific and PC-preferring enzymes, as well as sphingomyelinase, are produced by Bacillus cereus (80, 95, 198, 199). The genes encoding the three different proteins have been cloned and sequenced (84, 85, 96). PC-preferring and sphingomyelinase-encoding genes form a gene cluster (tandemly located) (59), which is not positioned in close proximity to the gene encoding phosphatidylinositol-specific PLC (59, 96). The PC-preferring enzyme has structural homology to the C. perfringens alpha-toxin (103), while the phosphatidylinositol-specific enzyme has stretches of sequence homology to other eukaryotic phospholipases (97).
The contribution of phospholipases to the virulence of B. cereus has not been investigated in animals. Although PLC of this bacterium is considered to be nontoxic (126), data suggestive of its involvement in host cell lysis have been reported. Gilmore et al. (59) suggested that by creating a duplex hemolysin named cereolysin AB, the PC-preferring phospholipase and the sphingomyelinase act in concert to cause hemolysis. Others (212) showed that B. cereus strains producing PLC cause degranulation of human neutrophils with a dose-dependent release of lysosomal enzymes, which may mediate tissue damage. Finally, it has been suggested that B. cereus protects itself against phagocytosis by releasing phospholipases (152).Rickettsia. Two species of the genus Rickettsia (Rickettsia rickettsii and Rickettsia prowazekii) were shown to possess PLA that was suggested to mediate host cell lysis (63, 177, 220, 222). Previously, Winkler and Miller (221) reported that rickettsiae enter cells through a mechanism involving a PLA. Their hypothesis was based on the demonstration that host cells exposed to large numbers of R. prowazekii release considerable amounts of lysophospholipids and free fatty acids into the culture medium. Involvement of phospholipases in the penetration and damage of host cells by R. rickettsii was first suggested by Walker et al. (207). More recently, Silverman et al. (177) confirmed these findings and provided suggestive evidence that phospholipase activity associated with internalization of this intracellular parasite lies directly with the infecting organism rather than with the host cell. However, as stated by the authors, definitive evidence that the phospholipase originates from these organisms could be provided only by isolation and cloning of specific rickettsial gene(s) involved in the internalization process (177).
Corynebacterium pseudotuberculosis. Corynebacterium pseudotuberculosis, the agent of caseous lymphadenitis in small ruminants and ulcerative lymphangitis in horses, produces extracellular PLD, which possibly plays a role in the pathogenicity of this and similar bacteria (Corynebacterium ulcerans and Arcanobacterium haemolyticum) (1, 34, 118, 184). The genes encoding the PLD in C. pseudotuberculosis and A. haemolyticum have been cloned and sequenced (118). Targeted mutagenesis of PLD in C. pseudotuberculosis reduced the ability of this bacterium to establish a primary infection or cause chronic abscess formation in regional lymph nodes (117). These results indicate that PLD is a virulence determinant of C. pseudotuberculosis, increasing the persistence and spread of the bacteria within the host (117).
Protozoan Phospholipases
Phospholipase A facilitates host cell penetration by the two protozoan species Toxoplasma gondii and Entamoeba histolytica.
Indirect evidence implicating a calcium dependent-PLA2 in host cell invasion by T. gondii was obtained by Saffer et al. (160), who showed that incorporation of exogenous PLA2 from snake venom increases host cell penetration by T. gondii. Furthermore, penetration of host fibroblasts by the parasite was inhibited following preincubation with PLA2 inhibitors, such as p-bromophenacyl bromide and nordihydroguaiaretic acid, or antisera to this enzyme (160). In another study, the same group extended these findings and demonstrated that treating fibroblasts with fractions of disrupted T. gondii led to accumulation of degradation products of the phospholipids (fatty acids and lysophospholipids). The data suggest that PLA may be associated with T. gondii cells (161). Moreover, fractions of T. gondii that had PLA enzymatic activity also increased host cell penetration (161). Although the findings of Saffer and Schwartzman (161) implicate phospholipases in the process of penetration of host cells by T. gondii, these workers used a crude enzyme preparation, which makes interpretation of the results quite difficult. To unequivocally establish a correlation between PLA and T. gondii virulence and to elucide how the enzyme may influence the penetration process of host cells by this parasite, gene cloning and enzyme purification are required.
E. histolytica, similar to T. gondii, possesses PLA (106, 153). Ravdin and coworkers (106) reported that this ameba has two PLA enzymes: a calcium-dependent protein which is associated with the plasma membrane and is most active at an alkaline pH, and a calcium-independent enzyme that is localized predominantly to soluble subcellular fractions of E. histolytica and is optimally active at an acidic pH. Amebic cytolytic activity, and thereby virulence, is associated with the calcium-dependent PLA. However, as in the case with T. gondii, definitive demonstration of the role of amebic PLA enzymes in the cytolytic event awaits their purification, gene cloning, and disruption.
PHOSPHOLIPASES IN PATHOGENIC FUNGI
|
|
|---|
Phospholipases of Candida albicans
The overall incidence of Candida bloodstream infections has increased significantly in the last two decades (9, 140, 143), ranging from a 75% increase in small hospitals to an over 400% increase in some large tertiary-care centers (140). This increase led to a tremendous interest in the study of candidal pathogenesis and strategies for control and prevention of this clinically important fungus. Candidal virulence factors have also attracted interest as a possible means for developing novel therapeutic interventions against candidiasis (33, 52, 139). Such virulence factors include adherence (20, 55, 90), germination (180), extracellular proteinases (71, 72) and phospholipases (75), and phenotypic switching (181, 182).
Early work on candidal phospholipases.
(i) Candidal phospholipase. The secretion of extracellular phospholipases by C. albicans was first reported in the 1960s by Costa et al. (A. Costa, A. Misefari, and A. Amaro, Abstr. Atti XIV Congr. Naz. Microbiol. Messina, abstr. P35 and P36 1967) and Werner (213) by growing the yeast on solid media containing egg yolk or lecithin and analyzing the lipid breakdown products. Later, phospholipase activity was found in many pathogenic C. albicans strains by using media containing blood serum and sheep erythrocytes (30). The observation that C. albicans secretes phospholipase prompted Pugh and Cawson (150) to develop a lecithin-based cytochemical method to detect this enzyme. In a subsequent study, these authors used this method (149) in conjunction with a chicken chorioallantoic membrane model to evaluate ultrastructural details of candidal invasion and to determine the site of phospholipase production. Invasion was initiated by placing stationary-phase blastospores of C. albicans on the membrane, which stimulated cellular changes in the blastospores. Many of the blastospores developed hyphae with phospholipase activity concentrated at the growing tip. The activity was highest where the hyphae were in direct contact with the membrane (149). In general, only hyphae invaded the membrane successfully. Based on these results, the investigators proposed that extracellular phospholipases were important in the invasion of tissue by C. albicans.
Subsequent studies by other groups were directed at developing simple methods to detect candidal phospholipases. Odds and Abbott (132) described a biochemical assay to measure intracellular PLA and Lyso-PL activity in C. albicans. By using this assay, it was found that PC was hydrolyzed to give Lyso-PC. A small amount of this degradation product was always detected (132). One disadvantage of this assay is that it is time-consuming and therefore unsuitable for testing a large number of isolates. Price et al. (147) described a plate method for the detection of phospholipase activity in C. albicans which circumvents this disadvantage. Since egg yolk contains large amounts of phospholipids, predominantly PC and phosphatidylethanolamine, it was incorporated into a Sabouraud dextrose agar-based medium. When grown on this medium, phospholipase-positive candidal isolates produce a distinct, well-defined, dense white zone of precipitation around the colony (Fig. 2). This white zone is probably due to the formation of calcium complex with the fatty acids released by the action of phospholipase on the phospholipids present in the egg yolk (110). In this assay, phospholipase activity (expressed as a Pz value) is defined as the ratio of colony diameter to the diameter of the dense white zone of precipitation around phospholipase positive colonies. This easy plate method became the traditional screening method for phospholipase activity for Candida species (66, 99, 168, 215) and other fungi such as Cryptococcus neoformans (23). However, because egg yolk contains substrates for both phospholipases (phospholipids) and lipases (triglycerides), the egg yolk-based assay is not specific, and therefore its use should be limited to initial screens only (49). Furthermore, the assay is not suitable for the screening of fungal isolates that produce low levels of phospholipase. Confirmation of phospholipase activity necessitates the use of a specific radiometric (10) or colorimetric (122, 176) assay and the use of concentrated culture filtrate, particularly in poorly phospholipase-producing strains. Awareness of this caveat is especially relevant for researchers attempting to determine the phospholipase activity of genetically manipulated mutants, e.g., phospholipase-deficient clones generated by site-specific mutagenesis (49, 101).
|
(ii) Production of phospholipase by various candidal species. Early studies in which the egg yolk-based assay was used to evaluate the ability of different Candida species to produce phospholipase showed that only C. albicans and not other species of Candida produce extracellular phospholipase. Samaranayake et al. (168) screened 41 Candida isolates for phospholipase activity by using a plate assay method and found that 79% of the C. albicans strains tested produced extracellular phospholipases whereas no strains of C. tropicalis, C. glabrata, and C. parapsilosis produced the enzymes. The quantity of phospholipase produced by C. albicans varied with the specific isolate and correlated with the site of infection. Blood isolates generally produce much higher levels than do isolates from wounds or urine (147). In contrast, Clancy et al. (C. J. Clancy, M. A. Ghannoun, and M. H. Nguyen, Programs Abstr. 36th Annu. Meet. Infect. Dis. Soc. Am., abstr. 317, 1998) recently showed that non-albicans Candida species produce extracellular phospholipases as determined by both egg yolk-based and colorimetric assays. In this study, 41% of C. glabrata, 50% of C. parapsilosis, 70% of C. tropicalis, 80% of C. lusitaniae, and 100% of C. krusei strains produced detectable phospholipase activity. However, it is important to emphasize that relative to C. albicans, the non-albicans species secreted significantly smaller amounts of phospholipase (for example, C. krusei has approximately 10 times less phospholipase activity [P. Mukherjee and M. Ghannoum, unpublished data]). Although Clancy et al. demonstrated that non-albicans species can secrete phospholipase similar to C. albicans, it is important to point out that the number of candidal isolates tested was limited (n = 51). Therefore, the percentages reported in this study may have been significantly different if a larger number of isolates had been examined. Furthermore, the discrepancy observed by different workers in the phospholipase activity for the non-albicans species may be attributed to strain-to-strain variation or differences in the preparation of the egg yolk agar plates used to detect phospholipase secretion in these species.
Lane and Garcia (99), using an egg yolk-based assay, tested the ability of C. albicans switching variants (wild type, star, stipple, and ring) to produce phospholipase (181). Star and ring variants produced a similar amount of phospholipase to the wild type. In contrast, the stipple variant produced between 27 and 34% more phospholipase than did the other three strains tested. Although candidal switching is considered to be a virulence factor (181), the relevance of the findings of Lane and Garcia to candidal pathogenicity remains to be shown through in vivo experimentation.(iii) Types of candidal phospholipases. The literature contains contradicting reports on the number and specific types of phospholipase enzymes secreted by C. albicans. Costa et al. (Abstr. Atti XIV Cong. Naz. Microbiol. Messina, abstr. P35 and P36, 1967) reported the secretion of both PLA and PLC by this clinically important yeast. Their results were based on the isolation of palmitic acid and phosphatidylcholine from the proximity of candidal colonies cultured on Sabouraud agar supplemented with serum and sheep erythrocytes. Since this medium is not chemically defined, the sources of the hydrolysis products are uncertain. Banno et al. (10) performed a crude fractionation of the proteins in culture filtrates of C. albicans by using DEAE-Sephadex and then assayed the fractions for phospholipase activity. Their data suggested that C. albicans secreted three types of phospholipases: Lyso-PL, LPTA, and PLB. Takahashi et al. (193) purified two distinct forms of LPTA from culture filtrates of C. albicans. These candidal enzymes differed from mammalian enzymes in amino acid composition; however, the substrate specificities were not determined (193).
To determine the type and substrate specificity of phospholipases secreted by C. albicans, a high-phospholipase-producing strain was grown to late log phase and the supernatant was concentrated and assayed for phospholipase activity by using two complementary assays: a specific-substrate radial diffusion assay capable of differentiating between PLA, PLB, and PLC activities (64) and a colorimetric acyl coenzyme A-oxidase system (101). Only PLB activity was observed in the diffusion-based assay (128). In the colorimetric assay, the concentrated supernatant was incubated with a substrate that is specific for PLB (PC) or Lyso-PL (Lyso-PC) activities. Both PLB and Lyso-PL activities were detected in the supernatant, suggesting that there are two enzymes with individual activity, or one enzyme with two activities (see "Definition of phospholipases and rationale in considering them for a role in virulence" above). To resolve this dilemma, protein purification and gene cloning were undertaken. In collaboration with Yoshinori Nozawa (Gifu University, Gifu, Japan), we purified to homogeneity the protein responsible for candidal extracellular phospholipase activities. This enzyme is a glycoprotein with a molecular mass of 84 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The specific activities of the enzyme were 117 µmol/min/mg of protein for fatty acid release (hydrolase), and 459 µmol/min/mg of protein for PC formation (LPTA activity). The apparent Km of the hydrolase activity of the enzyme for 1-palmitoyl-sn-glycero-3-phosphocholine was 60.6 µM. PLB activity was optimal at pH 6.0. The activity of the purified enzyme was not dependent on divalent cations (Ca2+ and Mg2+) and was not inhibited by the addition of EDTA or EGTA (122). To characterize the functional activity of the purified enzyme, Mirbod et al. (122) used both the radiometric and colorimetric methods described above. In these assays the enzyme was incubated with a substrate that is specific for PLB activity or Lyso-PL activities. In addition, to determine the LPTA activity, Lyso-PC was incubated with the purified enzyme and the rate of production of PC was monitored. These studies revealed that the purified C. albicans enzyme has both hydrolase (PLB and Lyso-PL) and LPTA activities. The finding that one enzyme has two hydrolase activities is not unique to C. albicans. A similar observation has been reported for PLB secreted by Penicillium notatum. Saito et al. (164) reported that P. notatum PLB is a glycoprotein with intrinsic Lyso-PL and PLB activities. Similarly, Lee et al. (100) showed that the Saccharomyces cerevisiae PLB1 gene encodes a protein required for Lyso-PL and PLB activities. These data clearly demonstrate that the purified enzyme is a phospholipase with dual activities. Similar to the candidal enzyme, PLB from S. cerevisiae is reported to have an acyltransferase activity (224, 225). This complex pattern of activity led to difficulties in the nomenclature of the fungal enzyme (see above). Further evidence that candidal PLB has both PLB and Lyso-PL activities was obtained by assaying phospholipase activities in supernatants from the parent and PLB1-deleted mutants (see below for construction and characterization of mutants). Unlike the parent, deletion of caPLB1 led to loss of both PLB and Lyso-PL activities. The phospholipase activities described so far are due to secreted candidal enzymes. Recently, McLain and Dolan (116) reported on a membrane-associated enzyme in C. albicans. This enzyme has a PLD activity and is capable of performing a transphosphatidylation reaction in the presence of primary alcohols (see below for cloning of candidal PLD).Evidence correlating phospholipases and virulence. Although the contribution of phospholipases to the pathogenesis of bacteria and protozoa has been known for some time, investigations into whether these enzymes are associated with fungal virulence have only recently been undertaken. Barrett-Bee et al. (11) was the first to evaluate the role of extracellular candidal phospholipases in virulence by using a murine model of candidiasis. When phospholipase activity was measured in six yeasts (four strains of C. albicans and a single strain each of C. parapsilosis and S. cerevisiae), a correlation was found between phospholipase activity and two potential parameters of pathogenicity. The C. albicans isolates which adhered most strongly to buccal epithelial cells and were most pathogenic in mice had the highest phospholipase activities. Less pathogenic isolates of C. albicans, C. parapsilosis, and S. cerevisiae were less adherent to epithelial cells and less lethal to mice and had lower phospholipase activities (11). Although these findings suggest a correlation between phospholipase activity and candidal virulence, the strains used were not genetically related, and therefore the differences observed in the virulence of the tested strains could be attributed to factors other than phospholipase secretion.
Two strategies were followed by Ibrahim et al. (75) to determine the role of phospholipase in candidal virulence: (i) the ability of blood isolates of C. albicans from patients and oral isolates from healthy volunteers to produce phospholipase were compared, and (ii) the pathogenicity of clinical isolates with different levels of phospholipase secretion was compared in a murine model of disseminated candidiasis (75). In the first comparative study, 22 isolates of C. albicans were tested (11 were blood isolates obtained from patients with disseminated candidiasis, and 11 were commensal isolates recovered from the oral cavities of healthy volunteers). Marked differences among strains from the two sources were observed. Significantly higher levels of phospholipase production were found in the blood isolates than in the commensals (P = 0.0081). In addition, the blood isolates had significantly higher rates of germination (P = 0.03), and their germ tubes were longer than the germ tubes formed by the commensal strains (P = 0.016). These findings suggest that blood isolates, unlike commensals, may have enhanced the expression of several virulence factors, including both germination and phospholipase production, to enable them to invade host tissues (75). In the same study, Ibrahim et al. (75) prospectively examined nine blood isolates for expression of virulence factors, including phospholipase and proteinase production, adherence, germination, growth rate, and ability to damage endothelial cells. Additionally, the mortality of mice infected with each of these isolates was determined and the predictive value of each virulence factor for mortality was determined by Cox proportional-hazards analysis. Of the virulence factors studied, only extracellular phospholipase activity was predictive of mortality (75). To obtain further evidence of the contribution of phospholipases to candidal pathogenicity, the virulence of two C. albicans isolates, CA30 and CA87, was compared in an infant-mouse model (28). Strain CA87 failed to cross the bowel wall of the infant mouse after oral-intragastric challenge and did not cause disseminated infection, while strain CA30 was able to cross the bowel wall and to disseminate hematogenously. A variety of putative virulence factors of these two strains were measured in vitro to determine the relationship of these factors to virulence (75). The only apparent difference in expression of virulence factors between the two strains was in the superior ability of CA30 to produce phospholipase (75). Since this strain was distinguished from CA87 by its ability to invade the bowel wall and undergo subsequent hematogenous dissemination and tissue invasion, these data further suggest that phospholipase is involved in the invasion process of C. albicans. Although these studies provide evidence that implicates phospholipases in the pathogenesis of C. albicans, they do not prove this association. As in the study of Barrett-Bee et al. (11), the candidal isolates used were not genetically related. The use of such strains does not rule out the possibility that differences observed in the virulence of these strains could be attributed to factors other than phospholipases. Thus, the correlation found between phospholipase and candidal virulence should be confirmed by the use of an isogenic strain pair that differs only in phospholipase production. Molecular cloning of the candidal gene(s) encoding the extracellular phospholipases is the essential first step in the molecular genetic dissection of the role of these enzymes in pathogenesis.Cloning of the gene(s) encoding candidal phospholipases. Efforts to clone genes encoding candidal phospholipases have resulted in the cloning of two genes encoding PLB (caPLB1 and caPLB2) and one gene (caPLD) coding for PLD.
(i) Candidal phospholipases B.
(a) caPLB1.
The C. albicans PLB1 gene was cloned by using a
PCR-based approach relying on degenerate oligonucleotide primers designed on the basis of the amino acid sequences of two peptide fragments obtained from a purified candidal enzyme displaying phospholipase activity (122). Sequence analysis of a 6.7-kb
EcoRI-ClaI genomic clone revealed a single open
reading frame of 1,818 bp that predicts a preprotein of 605 residues.
The size of the candidal PLB1 protein is similar to those reported for
other fungal PLBs, which ranged between 612 and 664 amino acids (Table
2). The genomic DNA sequence encodes 17 amino acid residues that are absent from the NH2 terminus
of the mature protein. This stretch of residues represents a possible
signal sequence (111, 169). The predicted protein contains
seven Asn-X-Ser/Thr motifs (residues 199, 261, 399, 451, 465, 492, and
573) that could potentially be N glycosylated. One possible tyrosine
phosphorylation site, Lys-Ser-Asn-Ile-Asp-Val-Ser-Ala-Tyr (residues 369 to 377), was also identified (101). Hydropathy analysis of
the predicted protein sequence (98) revealed the presence of
a single stretch of hydrophobic amino acids present at the amino
terminus (residues 1 to 18). This segment of amino acids most probably
functions as a single peptide which targets the protein to the
endoplasmic reticulum for subsequent processing and, ultimately,
secretion. Comparison of the putative candidal phospholipase with other
proteins in the redundant database (BLASTP program) revealed
significant homology to known fungal PLBs from S. cerevisiae
(45%), P. notatum (42%), Torulaspora
delbrueckii (48%), and Schizosaccharomyces pombe
(38%) (Fig. 3). This gene, designated
caPLB1, was mapped to chromosome 6 (101).
Consistent with our findings, Hoover et al. (69a) used
degenerate oligonucleotide primers derived from conserved regions of
PLB1 genes from S. cerevisiae and other fungi to
clone the corresponding candidal homolog. Their results confirm our
findings and the identity of caPLB1.
|
|
|
(ii) Candidal phospholipase D. PLD catalyzes the hydrolysis of PC to produce phosphatidic acid and choline (Fig. 1a above). Both mammalian and fungal (S. cerevisiae) genes encoding PLD have been cloned and characterized (130, 206). Mammalian PLD has emerged as one of the key enzymes in intracellular signaling (44), while PLD from S. cerevisiae (encoded by SPO14) is essential for meiosis (41, 158, 206). The absence of meiosis in C. albicans, which, unlike S. cerevisiae, exists as a diploid, indicates that PLD in this clinically important yeast may play other roles than meiosis. McLain and Dolan (116) have recently shown that PLD may be an important regulator of the dimorphic transition. Since this yeast-hypha transformation is thought to be an important virulence determinant in C. albicans (33, 54, 133), cloning and disruption of candidal PLD may contribute to our understanding of the biological role of this phospholipase.
For cloning candidal PLD, Kanoh et al. (87) designed two oligonucleotide primers based on the conserved amino acid sequences in human PLD1a and SPO14. These primers were used in a PCR-based approach to clone the full-length gene. The cloned PLD sequence had a potential open reading frame encoding a protein of 1,710 amino acids with a calculated molecular mass of 196.4 kDa. The putative ATG codon was surrounded by the consensus Kozak sequence for translation initiation (94), and the in-frame stop codon and the putative TATA box sequence (TATATAA) were found 6 and 172 bases upstream from the start codon, respectively. The deduced amino acid sequence contained the four conserved regions (I, II, III, and IV) defined by the primary structures of plant, yeast, and human PLDs (125). Furthermore, the HKD motif (HxKxxxxD) in regions I and IV and a serine residue in the GSRS motif in region IV, which are critical for PLD biochemical activity (189), were also completely conserved. The number of amino acids and the calculated molecular mass of C. albicans PLD closely resembled these of SPO14 protein (1,683 amino acids; 195 kDa). Comparison of the primary structure with those of other PLDs showed that it had the highest homology to the SPO14 protein. The overall homology between the amino acid sequences of C. albicans PLD and the SPO14 protein was 42%. At the four conserved regions, the homology between C. albicans PLD and the SPO14 protein ranged from 65 to 71%, while that between C. albicans PLD and rat PLDs was 42 to 55%. In addition to the four conserved regions found in both fungal and mammalian PLDs, candidal PLD has seven regions (A to G) of 10 to 91 amino acids that are highly homologous to SPO14 protein. Of the seven regions, only two, F and G, are conserved in mammalian PLDs. Therefore, Kanoh et al. (87) speculated that these five regions (A to E) may compose some functional domains specific for fungi. A phylogenetic tree for PLDs of various species showed three major clusters (87). The first cluster is composed of mammalian PLD1 and plant (151, 209), nematode, and Streptomyces PLDs. The second cluster was composed of mammalian PLD2, and the third cluster was composed of fungal PLDs, including C. albicans PLD and the SPO14 protein. Because fungal PLDS are in a separate grouping from mammalian and other PLDs, it is tempting to speculate that this enzyme may serve a fungus-specific function(s). Unfortunately, elucidation of the biological function of candidal PLD awaits the disruption of the gene encoding it.Disruption of phospholipase B1. Gene disruption (deletion) is frequently used to determine the functionality of a specific gene. This is particularly relevant in assessing the contribution of a given gene to microbial virulence (45). Several workers have disrupted a number of genes to evaluate their contribution to the virulence of C. albicans (37, 61, 74, 170, 228). Most recently, C. albicans strains with deletions of the INT1 gene, which encodes a cell surface protein with similarity to mammalian integrins, were constructed (50). Adhesion, hyphal formation, and virulence were subsequently found to be correlated with the expression of this gene.
The successful cloning of caPLB1 allowed us to construct PLB-deficient mutants by targeted gene disruption by using the ura-blaster technique (47) (see reference 101 for details of the method used to disrupt caPLB1). Initial disruption of caPLB1 was complicated by the finding that three rounds of transformation were required to delete the gene, suggesting that strain CAI-4 (a candidal strain derived from C. albicans SC5314 by deletion of the ura3 gene) was triploid for this locus. This finding seemed plausible since disruption of the C. albicans chitin synthase (CHS2) and catalase (CAT1) genes also revealed that they are triploid (61, 226). However, chromosome-blotting experiments suggested that the triallelic state of the caPLB1 genetic locus probably originated from a gene duplication/translocation event rather than an inherent triploid state in the parental strain. Given the above finding, we proceeded to disrupt the caPLB1 gene a second time, starting with the original CAI-4 strain. Chromosomal analysis was performed at every stage of this second disruption as a means of screening newly constructed strains for genetic translocation or incorrect targeting of transforming DNA. Southern hybridization, chromosomal analysis, and measurement of functional activity confirmed the successful disruption of caPLB1 and demonstrated that Candida is diploid for this locus (101). Although we cannot discount the fact that some candidal genes may be aneuploid (61, 226), our study with caPLB1 highlights the importance of fully characterizing the nature of a suspected triploidy even if mutant strains are constructed by the generally reliable technique of targeted gene disruption. Similar experience has been encountered by a number of Candida researchers (personal communications); therefore, intensive molecular genetic analysis of the constructed mutants should be undertaken so as to disclose potential mutations that otherwise go undetected, especially if disruption of the gene in question produces no obvious phenotypic defect.Phenotypic characterization of phospholipase B1-deficient mutants. Phenotypic characterization of the parent and deletion mutants is necessary prior to evaluating the virulence of the isogenic strain pair. Such characterization may provide some measure of assurance that deleting the caPLB1 gene results in only loss of PLB production and not other unrelated phenotypic properties. Comparison of the growth rates and germination capabilities of PLB-deficient mutant with that of the parental strain revealed that disruption of caPLB1 did not affect growth and germination of C. albicans (101), indicating that caPLB1 is not essential for these processes.
Disruption of caPLB1 reduced the ability of C. albicans to secrete the enzyme. When examined by Western blot analysis, PLB was found only in culture filtrates produced by parental and plb1-
1 strains but not in the supernatant produced
by strain plb1-
2 (null mutant). Furthermore, assay of
supernatants collected from the parent and the PLB-deficient mutants
for PLB and Lyso-PL activities by using specific substrates revealed
that the two activities were reduced in the PLB-deficient mutant by
approximately 99 and 80% respectively, relative to the wild type. The
residual phospholipase activities secreted by the
caPLB1-deficient strain may be the result of an additional
candidal phospholipase-encoding gene. In this regard, a second gene,
caPLB2, which has significant homology to caPLB1,
was recently cloned by our group (see "Candidal phospholipases B"
above). Experiments to delete this second gene are under way. Characterization of mutants with caPLB1 and
caPLB2 deleted may clarify the source of the residual
phospholipase activity observed in caPLB1-deficient mutant.
Testing of phospholipase B1-deficient mutants in murine models of candidiasis. Two different models of candidiasis, representing different clinical settings, were used to determine the role of caPLB1 in the virulence of C. albicans: (i) a hematogenous-dissemination murine model (58) and (ii) an oral-intragastric infant mouse model (28).
(i) Hematogenous-dissemination model.
Leidich et al.
(101) challenged BALB/c mice with 5 × 105
yeast cells of either the parent or the PLB-deficient strains
intravenously through the lateral tail vein. Both survival and tissue
fungal burden were used to assess the pathogenicity of the infecting strains. Their data showed that all mice infected with parental strain
SC5314 succumbed to candidal infection within 9 days. In contrast, 50 and 60% of mice challenged with either the PLB-deficient strain
plb1-
1 or plb1-
2, respectively, were
alive at day 15. The mean survival time ± standard deviation for
mice infected with parent was 4.4 ± 2.1 days, compared to
12.7 ± 2.7 and 13.3 ± 2.6 days for mice infected with
plb1-
1 or plb1-
2, respectively.
Statistical analyses revealed that mice infected with either strain
plb1-
1 or plb1-
2 survived significantly
longer than did mice infected with strain SC5314 (P < 0.0001 for both comparisons).
1 and plb1-
2 were cleared
significantly faster from the kidneys and brain than was parental
strain SC5314. For example, the mean fungal burden in the kidneys ± standard deviation was 6.13 ± 0.05 and 4.33 ± 0.35 CFU/g
of tissue for the parent and plb1-
2 mutant, respectively
(P < 0.004). The relative rates of clearance were as
follows: plb1-
2 > plb1-
1 > SC5314.
Taken together, these findings demonstrate that caPLB1 is
associated with candidal virulence. Survival and tissue fungal burden data showed that mortality of and tissue invasion in mice infected with
strain plb1-
1, which harbors only a single deleted
caPLB1 allele, was also significantly reduced compared to
those for the wild type, suggesting that there may be a dose-dependent
relationship between PLB and virulence. Thus, a threshold level of PLB
may be required to effectively enhance candidal virulence. In this
regard, analysis of culture filtrates for PLB activity revealed that
the levels of free fatty acid activity, relative to the parent,
released from dipalmitoyl-PC following incubation with culture
filtrates obtained from CAI-4, plb1-
1, and
plb-
2 were 100, 54, and 1%, respectively. Moreover, the
fact that deletion of caPLB1 did not render C. albicans strains completely avirulent underscores the notion that
candidal pathogenicity is multifactorial and is regulated by more than
one determinant (33).
(ii) Oral-intragastric infant-mouse model. Seshan et al. (174) used an oral-intragastric infant-mouse model to examine the effect of caPLB1 on the ability of C. albicans to traverse the gastrointestinal barrier and colonize systemic target organs, such as the kidneys and liver. This model simulates candidal migration across the gastrointestinal tract, one of the major routes for contracting disseminated candidiasis (131). In these experiments, inbred infant mice [crl:CFW (SW) BR] were inoculated intragastrically with 2 × 108 blastospores of either the wild-type or caPLB1-deficient strain. Transmigration of candidal cells across the gastrointestinal tract was monitored microscopically as well as by determining tissue fungal burden of target organs.
The histopathologic appearance of the gastric mucosa of mice infected with the parental strain differed markedly from that of mice infected with the PLB-deficient mutant. Light and transmission electron microscopic examination revealed yeast and hyphal elements in the gastric mucosa 14 days postchallenge. Fungal elements were observed after challenge with both the parental and PLB-deficient strains. However, mucosal invasion in mice challenged with the PLB-deficient strain was confined to the stomach lumen and inner layers of the gastric mucosa, and a minimal neutrophil-dependent inflammatory response was elicited. Furthermore, several areas of the stomach revealed no demonstrable infection. In contrast, the parental strain invaded the submucosal tissue of the stomach, elicited a neutrophil-dependent inflammatory response, and produced systemic candidiasis to a far greater extent. Additionally, the parental strain was able to transverse the vasculature, since numerous hyphal elements were observed within blood vessel lumens (see below) (174). The number of mice that developed systemic candidal infections differed markedly following challenge with either the parental or PLB-deficient strain. Of the mice challenged with the parental strain, 90 and 70%, respectively, exhibited liver and kidney colonization. In contrast, only 45 and 27% of mice infected with the PLB-deficient mutant exhibited liver and kidney involvement, respectively (174). This difference was reflected in the number of candidal cells (CFU) recovered from these organs. The relative candidal cells recovered from the kidneys and liver of mice challenged with the parental or caPLB1-deficient strain were 2.05 ± 0.4 and 0.77 ± 0.4 CFU/g for the kidney and 2.87 ± 0.4 and 1.33 ± 0.4 CFU/g for the liver, respectively. These differences were statistically significant (P values for kidneys and liver were 0.042 and 0.014, respectively). The findings of Seshan et al. (174) that the parental strain was more efficient at crossing the gastrointestinal tract and invading internal organs than was its PLB-deficient counterpart suggest a role for PLB in candidal transmigration across the gastrointestinal tract and subsequent dissemination to target organs. Furthermore, their study presents further evidence in support of PLB as a virulence determinant for C. albicans. Finally, the results of the studies of Leidich et al. (101) and Seshan et al. (174) indicate that candidal PLB may be critical for dissemination of C. albicans by the gastrointestinal and hematogenous routes.Expression of phospholipase B1 during host tissue invasion. One of the criteria to prove that a particular gene or its product plays an important role in the disease process is to show that it is expressed by the microorganism during the infectious process (45, 167). Both the hematogenous-dissemination (101) and oral-intragastric mouse (174) models for candidiasis were used to determine whether PLB is secreted in vivo.
In the hematogenous-dissemination model, Leidich et al. (101) challenged mice with either the parental or the caPLB1-deleted mutant. Kidneys were harvested, and sections were processed for immunoelectron microscopy by being incubated with either PLB antiserum or goat serum, which served as a negative control. The data revealed that while PLB was secreted from the parental strain during the infectious process, as evidenced by the formation of immunogold complexes following incubation of the tissue sections with PLB antiserum, it was not secreted from the PLB-deficient mutant. In other experiments, C. albicans cells were recovered from the kidneys of mice infected with either the parental or the PLB-deficient strain and prepared for immunogold electron microscopy. Sections examination showed that immunogold labeling was observed only with cells recovered from mice infected with the wild type strain and not with cells recovered from animals infected with the PLB-deficient mutant (J. Vitullo, S. D. Leidich, C. J. Jessup, and M. A. Ghannoum, Program Abstr. 98th Gen. Meet. Am. Soc. Med., abstr. F-39, 1998). These data demonstrate that C. albicans secretes PLB during the invasion of target organs. Moreover, deletion of PLB abrogate the fungal cell ability to secrete this lytic enzyme (see "Phenotypic and genotypic characterization of phospholipase B1-deficient mutants" above). Using indirect-immunofluorescence microscopy, Seshan et al. (174) investigated the expression of PLB during the course of candidal transmigration across the gastrointestinal tract of infant mice. Following challenge with either the parent or the PLB-deficient strain, mice were sacrificed and their gastric mucosal tissues were removed and prepared for indirect-immunofluorescence microscopy. The data showed that the vast majority of candidal cells secrete PLB. Both hyphal and yeast forms of C. albicans secreted the enzyme. Although the periphery of most cells exhibited low-level fluorescence suggestive of PLB secretion, intense fluorescence was observed at the growing tips of mature and developing hyphae, suggesting that PLB secretion is concentrated at the invading hyphal tip. This phenomenon was strikingly clear when immunogold transmission electron microscopy was used to localize PLB secretion in the stomach of infected mice (Fig. 5).
|
Phospholipases of Candida glabrata
C. glabrata is recognized increasingly as an important nosocomial pathogen (2, 89, 92, 146, 156, 201, 210, 214, 218, 219); D. W. Warnock, J. Burke, N. J. Cope, E. M. Johnson, N. A. Von Frauenhofer, and E. W. Williams, Letter, Lancet ii:310, 1988). It ranks third among Candida species in the number of reported cases of candidemia, and in one study, C. glabrata surpassed C. tropicalis to become the most common nonalbicans species isolated (51). C. glabrata is important clinically, not only because of the increase in its frequency but also because it is associated with high complication rates (51) and high mortality rates (7, 12). In one study, the mortality rate of 83% exceeded the observed rates from any other Candida species (92). Therefore, identification of factors that contribute to the virulence of this organism may provide new attractive therapeutic targets. Recently, Clancy et al. (Programs Abstr. 36th Annu. Meet. Infect. Dis. Soc. Am., abstr. 317, 1998) reported on the detection of extracellular phospholipase activity in C. glabrata and provided data implicating it as a virulence factor in patients with candidemia caused by this yeast. In their study, phospholipase activity (as determined by opacity around colonies growing on egg yolk-containing media) was investigated in 51 non-albicans Candida species (C. glabrata, 22; C. parapsilosis, 12; C. tropicalis, 10; C. lusitaniae, 5; C. krusei, 2) recovered from patients in a multicenter study of candidemia. Phospholipase activity was detected in 53% of isolates. An assay involving agar containing specific phospholipid substrates was used to identify the type of phospholipase activity secreted by C. glabrata (64). As with C. albicans, PLB and Lyso-PL accounted for 100% of phospholipase activity. No PLA or PLC activities were detected in supernatants collected from various C. glabrata isolates tested. To determine whether a correlation exists between phospholipase activity and clinical virulence, the authors classified the C. glabrata isolates into two groups: persistent isolates were strains that remained in the blood despite therapy with antifungal agents effective in vitro and despite removal of all intravenous catheters, and nonpersistent isolates were strains that were cleared. Among non-albicans Candida species tested, the association between phospholipase activity and persistent candidemia was strongest for C. glabrata (P = 0.004). Moreover, the median PLB and Lyso-PL activities were higher for persistent isolates (9.5 and 24 pmol/mg, respectively) than for nonpersistent isolates (0 and 5.8 pmol/mg) (P < 0.0001 and P = 0.02, respectively).
To establish the role of PLB in the pathogenesis of C. glabrata, an isogenic strain pair of this yeast which differed
only in PLB activity was created (C. J. Clancy, A. Leuin, M. A. Ghannoum, and M. H. Nguyen, Programs Abstr. 36th Annu. Meet.
Infect. Dis. Soc. Am., abstr. 316, 1998). Conserved sequences of
scPLB1, the gene responsible for PLB activity in S. cerevisiae, were used to design guessmer primers for PCR with DNA
from a clinical C. glabrata isolate. A 1,030-bp PCR product
that encoded part of a putative protein with 78% homology to
scPLB1 protein was generated. To create an isogenic mutant
with disruption of the PLB gene, Clancy et al. first created a
ura3
auxotroph of the parent C. glabrata strain. S. cerevisiae URA3, which is >80%
identical to C. glabrata URA3, was amplified by PCR,
BamHI restriction sites were added to either end, and the resulting product was inserted in the unique BamHI site of
the 1,030-bp PCR fragment. The disrupted product was liberated from the
plasmid by EcoRI digestion and was then used to transform C. glabrata ura3
auxotrophs. The resulting
mutants were selected by growth on Ura
media. Targeted
disruption was confirmed by Southern blot analysis. Colorimetric assay
of phospholipase activity revealed >90% elimination of both PLB and
Lyso-PL activities in the mutant isolate (URA3+
plb
) compared to the parent C. glabrata
(URA3+ plb+), confirming that the
cloned gene was responsible for the vast majority of PLB and Lyso-PL
activities. Comparative in vivo pathogenicity studies are currently
being performed to determine the role of the cloned gene in C. glabrata virulence.
Phospholipases of Cryptococcus neoformans
Cryptococcus neoformans is the cause of the most common life-threatening fungal infection in patients with AIDS. Depending on the study, estimates of the frequency of cryptococcosis among AIDS patients range from 5%